amlodipine has been researched along with bendroflumethiazide in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (13.04) | 18.2507 |
| 2000's | 13 (56.52) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Buckley, MG; Cappuccio, FP; MacGregor, GA; Markandu, ND; Miller, MA; Sagnella, GA; Singer, DR | 1 |
| Antonios, TF; Cappuccio, FP; MacGregor, GA; Markandu, ND; Sagnella, GA | 1 |
| Barrow, SE; Benjamin, N; Brett, SE; Ritter, JM; Stratton, PD; Woods, JD | 1 |
| Donnan, PT; Lim, PO; MacDonald, TM | 1 |
| Ebbs, D | 1 |
| Peuhkurinen, K; Risteli, J; Ruskoaho, H; Tokola, H; Uusimaa, P; Vuolteenaho, O; Ylitalo, A | 1 |
| Brown, MJ; Deary, AJ; Foo, RS; Haydock, SF; Murfet, H; Schumann, AL | 1 |
| Beevers, DG; Blann, AD; Gurney, D; Lip, GY; Spencer, CG | 1 |
| Kulschewski, A; Schrader, J | 1 |
| Füessl, HS | 1 |
| Borrild, N; Rasmussen, S; Vang Andersen, J | 1 |
| Feely, J; Mahmud, A | 1 |
| Blann, AD; Felmeden, DC; Lip, GY; Spencer, CG | 1 |
| Rahn, KH | 1 |
| Mehlsen, J | 1 |
| Campbell, NR; Dahlöf, B; Dobson, JE; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Wald, DS; Wald, NJ | 1 |
| Chang, CL; Dahlöf, B; Gupta, AK; Nasothimiou, EG; Poulter, NR; Sever, PS | 1 |
| Baksi, AJ; Barron, AJ; Fitzgerald, D; Hughes, AD; Jabbour, RJ; Mayet, J; O'Brien, E; Poulter, N; Sever, P; Sharp, A; Stanton, A; Surendran, P; Thom, S | 1 |
| Greenwood, JP; Negrou, K; Oliver, JJ; Plein, S; Ripley, DP; Struthers, AD; Worthy, G | 1 |
| Chong, SJ; Howard, KA; Knox, C | 1 |
2 review(s) available for amlodipine and bendroflumethiazide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Old or new antihypertensives--which are better?].
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Calcium Channel Blockers; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Perindopril; Risk; Risk Factors; Sodium Chloride Symporter Inhibitors; Time Factors | 2005 |
14 trial(s) available for amlodipine and bendroflumethiazide
| Article | Year |
|---|---|
A double-blind crossover study of the effect of concomitant diuretic therapy in hypertensive patients treated with amlodipine.
Topics: Adult; Amlodipine; Bendroflumethiazide; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Hypokalemia; Male; Middle Aged; Nifedipine; Potassium | 1991 |
A diuretic is more effective than a beta-blocker in hypertensive patients not controlled on amlodipine and lisinopril.
Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Treatment Failure | 1996 |
Prostacyclin biosynthesis in essential hypertension before and during treatment.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Amlodipine; Antihypertensive Agents; Bendroflumethiazide; Epoprostenol; Female; Humans; Hypertension; Isoquinolines; Male; Metoprolol; Middle Aged; Quinapril; Tetrahydroisoquinolines; Thromboxane A2; Thromboxane B2 | 1996 |
Does the Dundee Step Test predict outcome in treated hypertension? A sub-study protocol for the ASCOT trial. Anglo-Scandinavian Cardiac Outcome Trial.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Diuretics; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Humans; Hypertension; Incidence; Male; Middle Aged; Perindopril; Predictive Value of Tests; Survival Rate; Treatment Outcome | 2000 |
A comparison of selected antihypertensives and the use of conventional vs ambulatory blood pressure in the detection and treatment of hypertension.
Topics: Adult; Aged; Amlodipine; Analysis of Variance; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Diastole; Double-Blind Method; Doxazosin; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Systole; Treatment Outcome | 2001 |
Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bendroflumethiazide; Bisoprolol; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Doxazosin; Female; Heart Rate; Humans; Hypertension; Lisinopril; Male; Middle Aged; Natriuretic Peptide, Brain; Renin-Angiotensin System; Sodium Chloride Symporter Inhibitors | 2002 |
Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Cross-Sectional Studies; Electrocardiography; Female; Hematocrit; Hemorheology; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; P-Selectin; Perindopril; Regression Analysis; Single-Blind Method; Treatment Outcome; von Willebrand Factor | 2002 |
Efficacy and safety of 24 weeks of therapy with bendroflumethiazide 1.25 mg/day or 2.5 mg/day and potassium chloride compared with enalapril 10 mg/day and amlodipine 5 mg/day in patients with mild to moderate primary hypertension : a multicentre, randomis
Topics: Adult; Aged; Amlodipine; Bendroflumethiazide; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Potassium Chloride | 2006 |
Low-dose quadruple antihypertensive combination: more efficacious than individual agents--a preliminary report.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Calcium Channel Blockers; Capsules; Captopril; Diuretics; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged | 2007 |
Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Diuretics; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; P-Selectin; Perindopril; Platelet Activation; United Kingdom; Vascular Resistance; von Willebrand Factor | 2007 |
Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Europe; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Proportional Hazards Models; Treatment Outcome | 2009 |
Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk.
Topics: Aged; Algorithms; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Diuretics; Drug Resistance; Female; Humans; Hypertension; Ireland; Male; Middle Aged; Perindopril; Risk Factors; Scandinavian and Nordic Countries; United Kingdom | 2011 |
Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudy.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Drug Therapy, Combination; Echocardiography, Doppler; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Perindopril; Time; Treatment Failure; Ventricular Function, Left; White People | 2014 |
Aortic remodelling following the treatment and regression of hypertensive left ventricular hypertrophy: a cardiovascular magnetic resonance study.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Aorta, Thoracic; Bendroflumethiazide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Essential Hypertension; Female; Follow-Up Studies; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Sympatholytics; Treatment Outcome; Valsartan; Vascular Remodeling; Vascular Stiffness | 2015 |
7 other study(ies) available for amlodipine and bendroflumethiazide
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Atrial Natriuretic Factor; Bendroflumethiazide; Cardiomegaly; Endothelin-1; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Perindopril; Procollagen; Randomized Controlled Trials as Topic | 2001 |
[Antihypertensive therapy: campaign of the giants].
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Drug Therapy, Combination; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Survival Analysis | 2005 |
[Treating essential hypertension. Are beta blockers still first choice?].
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Drug Therapy, Combination; Humans; Hypertension; Multicenter Studies as Topic; Myocardial Infarction; Outcome Assessment, Health Care; Perindopril; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Stroke | 2007 |
[Hypertension--does it matter how blood pressure is lowered?].
Topics: Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Atorvastatin; Bendroflumethiazide; Cardiovascular Diseases; Cost-Benefit Analysis; Diuretics; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Heptanoic Acids; Humans; Hypertension; Perindopril; Pyrroles; Treatment Outcome | 2008 |
Implementation of a simple age-based strategy in the prevention of cardiovascular disease: the Polypill approach.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Bendroflumethiazide; Cardiovascular Diseases; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Patient Compliance; Primary Prevention; Risk Factors; Simvastatin | 2012 |
Hypokalaemia and drinking green tea: a literature review and report of 2 cases.
Topics: Aged; Amlodipine; Antihypertensive Agents; Bendroflumethiazide; Drinking Behavior; Female; Humans; Hypertension; Hypokalemia; Lisinopril; Male; Tea | 2016 |